Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride

International Journal of Pharmaceutics

Volumn 274, Issue 1-2, 2004, Pages 213-219

  Trottet, L ^a,c   Merly, C ^a   Mirza, M ^a   Hadgraft, J ^b   Davis, A F ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c GLAXOSMITHKLINE   (France)

Author keywords

Finite dose; In vitro; Loperamide; Percutaneous permeation; Propylene glycol

Indexed keywords

LOPERAMIDE; PROPYLENE GLYCOL;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREAM; DERMATOME; DRUG FORMULATION; DRUG PENETRATION; FEMALE; GEL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; DIFFUSION CHAMBERS, CULTURE; DRUG SYNERGISM; FEMALE; HUMANS; LOPERAMIDE; MIDDLE AGED; PERMEABILITY; PROPYLENE GLYCOL; SKIN;

EID: 1842505256     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.01.013     Document Type: Article

References (19)

1. Azurdia R.M., Pagliaro J.A., Diffey B.L., Rhodes L.E. Sunscreen application by photosensitive patients is inadequate for protection. Br. J. Dermatol. 140:1999;255-258.
2. Bech T.N., Wulf H.C. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol. Photoimmunol. Photomed. 9:1992;242-244.
3. Bendras, B., Neubert, R., Wohlrab, W., 1995. Propylene glycol. In: Smith, E.W., Maibach, H.I. (Eds.), Percutaneous Penetration Enhancers. CRC Press, Boca Raton, pp. 61-75.
4. Diembeck W., Beck H., Benech K.F., Courtellemont P., Dupuis J., Paye M., Spengler J., Steiling W. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association. Food Chem. Toxicol. 37:1999;191-205.
5. Howes D., Guy R., Hadgraft J., Heylings J., Hoeck U., Kemper F., Maibach H., Marty J.P., Merk H., Parra J., Rekkas D., Rondelli I., Schaefer H., Tauber U., Verbiese N. Methods for assessing percutaneous absorption - the report and recommendations of ECVAM workshop 13. ATLA. 24:1996;81-106.
6. Mollgaard B., Hoelgaard A. Vehicle effect on topical drug delivery. II. Concurrent skin transport of drugs and vehicle components. Acta Pharm. Suec. 20:1983;443-450.
7. Polano M.K., Ponec M. Dependence of corticosteroid penetration on the vehicle. Arch. Dermatol. 112:1976;675-680.
8. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 9:1992;663-669.
9. Pugh W.J., Roberts M.S., Hadgraft J. Epidermal permeability-penetrant structure relationships. 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int. J. Pharm. 138:1996;149-165.
10. Roberts M.S., Pugh W.J., Hadgraft J., Watkinson A.C. Epidermal permeability-penetrant structure relationships. 1. An analysis of methods of predicting penetration of monofunctional solutes from aqueous solutions. Int. J. Pharm. 126:1995;219-233.
11. Roberts M.S., Pugh W.J., Hadgraft J. Epidermal permeability: penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. Int. J. Pharm. 132:1996;23-32.
12. Skelly J.P., Shah V.P., Maibach H.I. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm. Res. 4:1987;265-267.
13. Smith, E.W., Maibach, H.I., 1995. Future perspectives for penetration enhancers. In: Smith, E.W., Maibach, H.I. (Eds.), Percutaneous Penetration Enhancers. CRC Press, Boca Raton, pp. 481-484.
14. Squier C.A., Kremer M., Wertz P.W. Continuous flow mucosal cells for measuring the in vitro permeability of small tissue samples. J. Pharm. Sci. 86:1997;82-84.
15. Squillante E., Needham T., Maniar A., Kislalioglu S., Zia H. Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin. Eur. J. Pharm. Biopharm. 46:1998;265-271.
16. Surber, C., Davis, A.F., 2002. Bioavailability and bioequivalence. In: Walters, K.A. (Ed.), Dermatological and Transdermal Formulations. Marcel Dekker, New York, Basel, pp. 401-498.
17. Tsai J.C., Cappel M.J., Flynn G.L., Weiner N.D., Kreuter J., Ferry J.J. Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions. J. Pharm. Sci. 81:1992;736-743.
18. Williams A.C., Cornwell P.A., Barry B.W. On the non-Gaussian distribution of human skin permeabilities. Int. J. Pharm. 86:1992;69-77.
19. Wotton P.K., Mollgaard B., Hadgraft J., Hoelgaard A. Vehicle effect on topical drug delivery. III. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm. 24:1985;19-26.